phospho-Caveolin-2 (Tyr19) Polyclonal Antibody, PE-Cy5.5 Conjugated, PE/Cy5.5, Rabbit

Produktübersicht

• Artikelname: phospho-Caveolin-2 (Tyr19) Polyclonal Antibody, PE-Cy5.5 Conjugated, PE/Cy5.5, Rabbit
• Artikelnummer: BSS-BS-7523R-PE-CY5.5
• Hersteller Artikelnummer: bs-7523R-PE-Cy5.5
• Alternativnummer: BSS-BS-7523R-PE-CY5.5-100
• Hersteller: Bioss
• Wirt: Rabbit
• Kategorie: Antikörper
• Applikation: WB
• Spezies Reaktivität: Mouse, Rat
• Konjugation: PE/Cy5.5
• Alternative Synonym: Caveolin 2 phospho Y19, p-Caveolin 2phospho Y19, CAV, CAV2, CAV2_HUMAN, Caveolae protein 20 kD, Caveolin 2, Caveolin 2 isoform a and b, Caveolin 2 isoform c, Caveolin-2, MGC12294, CAV2_HUMAN.

Produktbeschreibung

Cellular localization: Nucleus. Cytoplasm. Golgi apparatus membrane. Cell membrane. Membrane > caveola. Potential hairpin-like structure in the membrane. Membrane protein of caveolae. Tyr-19-phosphorylated form is enriched at sites of cell-cell contact and is translocated to the nucleus in complex with MAPK1 in response to insulin (By similarity). Tyr-27-phosphorylated form is located both in the cytoplasm and plasma membrane. CAV1-mediated Ser-23-phosphorylated form locates to the plasma membrane. Ser-36-phosphorylated form resides in intracellular compartments.

Produkteigenschaften

• Klonalität: Polyclonal
• Konzentration: 1ug/ul
• NCBI: 858
• Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
• Quelle: KLH conjugated syntheticphosphopeptide derived from mouse Caveolin2 around the phosphorylation site of Tyr19.
• Target-Kategorie: phospho-Caveolin-2 (Tyr19)

Anwendungsbeschreibung

• Application Verdünnung: WB(1:300-5000)